Synergy Pharmaceuticals to Present at AACR

Synergy Pharmaceuticals to Present at AACR
Synergy&#39s second GC-C agonist SP-333 is at present in pre-clinical development to treat inflammatory bowel diseases. Much more details is accessible at . Fox Chase Cancer Center is 1 of the top cancer study and …
Read far more on MarketWatch (press release)

Canadian College of Naturopathic Medicine Opens 1st Integrative Cancer
The OICC is each a therapy clinic and an integrative oncology analysis centre, which exists to assess and decrease attainable causes of cancer even though exploring innovative integrative strategies to treat the illness. The Centre&#39s clinical practice and …
Read more on Canada NewsWire (press release)